What’s got me thinking is the crazy SOI the CRs have caused.
Im only thinking this because DXB pathway to revenue is through licensing deals, which attract upfront payments and diminish the need for a CR.
But then how attractive would BOT (in particularly Sofdra) be if revenues were tied to other companies?
Is this the biggest indicator as to takeover being the endgame? Thoughts?
I could be completely wrong so don’t cuss me out to much.
- Forums
- ASX - By Stock
- BOT
- Current And Future Valuation 2025
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
0.00%
!
30.0¢

Current And Future Valuation 2025, page-193
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M |
Open | High | Low | Value | Volume |
30.5¢ | 31.0¢ | 30.0¢ | $2.131M | 7.020M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 504695 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 38124 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 40881 | 0.305 |
17 | 520162 | 0.300 |
11 | 487795 | 0.295 |
14 | 725860 | 0.290 |
13 | 819934 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 35000 | 1 |
0.300 | 5882 | 1 |
0.305 | 73924 | 4 |
0.310 | 321000 | 5 |
0.315 | 754032 | 7 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |